Whether you are planning to start a family or have already started the IVF process, Progenesis offers you a one-stop solution covering carrier screening, PGT-A, PGT-M, and prenatal test.

Progenesis is the first company in the US to introduce Next Generation Sequencing (NGS) for Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic disorders (PGT-M). We offer a range of products geared toward patients at all stages of family planning. All of our services are carefully designed with the patient in mind while staying up-to-date on the most recent trends in genetics and technology. Our carrier screening panel is the most comprehensive test available on the market today. We offer embryo screening for many common diseases including cystic fibrosis, Fragile X syndrome, sickle cell disease, and Tay-Sachs disease. We have introduced the most accurate test in the IVF field for 24-chromosome aneuploidy screening and single gene disorder.

To assess a patient’s risk of having a child with an inherited disorder before conception. For couples that have already begun IVF, preimplantation genetic screening and diagnosis can help select the best embryo for transfer. During pregnancy, as early as 10 weeks of pregnancy to evaluate the health of the fetus.

Together, our dynamic team is committed to making the IVF journey more fruitful and less stressful for our patients.